{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:24:46Z","timestamp":1765211086137,"version":"3.46.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010443","name":"University of Illinois","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010443","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009706","name":"Center on Health, Aging, and Disability","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>While many studies have explored the relationship between cannabis and opioid use, few have examined how individuals who use opioids only, cannabis only, or both substances differ in terms of sociodemographic and health-related characteristics. Understanding these differences may support the development of clinical and public health strategies addressing substance use patterns.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed data from the 2015\u20132022 National Survey on Drug Use and Health (NSDUH), focusing on US adults (\u226518\u202fyears) who reported past-year medical use of prescription opioids and\/or cannabis. Individuals were categorized into three mutually exclusive groups: opioid-only, cannabis-only, and opioid-cannabis co-use (OC). Descriptive statistics and weighted multinomial logistic regression models were used to compare characteristics across groups, adjusting for the complex survey design.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 134,402 adults, 49.5% used opioids only, 35.3% used cannabis only, and 15.2% reported co-use. Co-use was more common among younger adults, individuals with lower income, and those experiencing psychological distress. The impact of depression on the relative risk ratio (RRR) for opioid use only, relative to co-use, was similar to those on the RRR for cannabis use only (RRR\u202f=\u202f0.52; 95% CI: 0.49\u20130.56). However, for many characteristics, the RRR of opioid use only, vs. co-use, differed from that of cannabis use only, vs. co-use. Compared to co-users, individuals in the opioid-only group were more likely to be older, women, and reside in large-metro areas. In contrast, individuals in the cannabis-only group were more likely to be younger, men, report better health status, and reside in non-metro regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Individuals who use opioids only, cannabis only, or both substances differ significantly across demographic, socioeconomic, and health-related factors. These distinctions highlight the need for tailored clinical guidance and public health responses that account for co-use patterns and geographic context to support safer pain management and substance use care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2025.1623420","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:21:45Z","timestamp":1765210905000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Co-use of opioids and cannabis versus single-substance use: a national analysis of US adults"],"prefix":"10.3389","volume":"13","author":[{"given":"Hyojung","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jilin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Milavetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"ref1","year":"2021"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/01.J.PAIN.0000460357.01998.F1","article-title":"Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis","volume":"156","author":"Vowles","year":"2015","journal-title":"Pain"},{"key":"ref3","year":"2025"},{"key":"ref4","volume-title":"The health effects of Cannabis and cannabinoids: The current state of evidence and recommendations for research","year":"2017"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11916-023-01101-w","article-title":"Medical Cannabis for chronic nonmalignant pain management","volume":"27","author":"Hameed","year":"2023","journal-title":"Curr Pain Headache Rep"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.7417\/T.2018.2062","article-title":"Medical Cannabis in patients with chronic pain: effect on pain relief, pain disability, and psychological aspects. A prospective non randomized single arm clinical trial","volume":"169","author":"Poli","year":"2018","journal-title":"Clin Ter"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.pmn.2019.06.009","article-title":"Cannabis use motivations among adults prescribed opioids for pain versus opioid addiction","volume":"21","author":"Clem","year":"2020","journal-title":"Pain Manag Nurs"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s40266-022-00995-2","article-title":"Prevention, practice, and policy: older US veterans\u2019 perspectives on Cannabis use","volume":"40","author":"Bobitt","year":"2023","journal-title":"Drugs Aging"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1089\/can.2017.0012","article-title":"Cannabis as a substitute for opioid-based pain medication: patient self-report","volume":"2","author":"Reiman","year":"2017","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref10","year":"2024"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/mp.2016.252","article-title":"Cannabis use and risk of schizophrenia: a Mendelian randomization study","volume":"23","author":"Vaucher","year":"2018","journal-title":"Mol Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/j.2051-5545.2008.tb00158.x","article-title":"Cannabis use and the risk of developing a psychotic disorder","volume":"7","author":"Hall","year":"2008","journal-title":"World Psychiatry"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1086\/699620","article-title":"The impact of medical cannabis legalization on prescription medication use and costs under Medicare part D","volume":"61","author":"Bradford","year":"2018","journal-title":"J Law Econ"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1001\/jamainternmed.2014.4005","article-title":"Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010","volume":"174","author":"Bachhuber","year":"2014","journal-title":"JAMA Intern Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"12624","DOI":"10.1073\/pnas.1903434116","article-title":"Association between medical cannabis laws and opioid overdose mortality has reversed over time","volume":"116","author":"Shover","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/rapm-2022-103933","article-title":"Co-use of cannabis and prescription opioids in adults in the USA: a population-based, cross-sectional analysis of the NHANES from 2009 to 2018","volume":"48","author":"Diep","year":"2023","journal-title":"Reg Anesth Pain Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1176\/appi.ajp.2017.17040413","article-title":"Cannabis use and risk of prescription opioid use disorder in the United States","volume":"175","author":"Olfson","year":"2018","journal-title":"Am J Psychiatry"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/dar.12964","article-title":"Medical and non-medical cannabis use and risk of prescription opioid use disorder: findings from propensity score matching","volume":"38","author":"Liang","year":"2019","journal-title":"Drug Alcohol Rev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/ADM.0000000000000493","article-title":"Opioid and Cannabis co-use among adults with chronic pain: relations to substance misuse, mental health, and pain experience","volume":"13","author":"Rogers","year":"2019","journal-title":"J Addict Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"208942","DOI":"10.1016\/j.josat.2022.208942","article-title":"Opioid and cannabis co-use: the role of opioid use to cope with negative affect","volume":"145","author":"Buckner","year":"2023","journal-title":"J Substance Use Addiction Treatment"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/00952990.2021.1903479","article-title":"Biopsychosocial factors and health outcomes associated with cannabis, opioids and benzodiazepines use among older veterans","volume":"47","author":"Kang","year":"2021","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1080\/02791072.2017.1342153","article-title":"Association between nonmedical marijuana and pain reliever uses among individuals aged 50+","volume":"49","author":"Choi","year":"2017","journal-title":"J Psychoactive Drugs"},{"key":"ref23","volume-title":"National Survey on drug use and health (NSDUH)","year":"2023"},{"key":"ref24","volume-title":"2019 National Survey on drug use and health (NSDUH) methodological resource book: Section 2: Sample design report","year":"2020"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1037\/0893-164X.22.3.372","article-title":"Classes of substance abuse relapse situations: a comparison of adolescents and adults","volume":"22","author":"Ramo","year":"2008","journal-title":"Psychol Addict Behav"},{"key":"ref26","article-title":"Screening and treatment of substance use disorders among adolescents","year":"2021","journal-title":"Advisory"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1017\/S095457942000005X","article-title":"Different factors predict adolescent substance use versus adult substance abuse: lessons from a social-developmental approach","volume":"33","author":"Allen","year":"2021","journal-title":"Dev Psychopathol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e1002922","DOI":"10.1371\/journal.pmed.1002922","article-title":"Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study","volume":"16","author":"Hudgins","year":"2019","journal-title":"PLoS Med"},{"key":"ref29","year":"2021"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"e46742","DOI":"10.2196\/46742","article-title":"Differing behaviors around adult nonmedical use of prescription stimulants and opioids: latent class analysis","volume":"25","author":"Rockhill","year":"2023","journal-title":"J Med Internet Res"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1017\/S0033291702006074","article-title":"Short screening scales to monitor population prevalences and trends in non-specific psychological distress","volume":"32","author":"Kessler","year":"2002","journal-title":"Psychol Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/01621459.1992.10475190","article-title":"Generalized collinearity diagnostics","volume":"87","author":"Fox","year":"1992","journal-title":"J Am Stat Assoc"},{"key":"ref33","volume-title":"RStudio: Integrated development environment for R","year":"2023"},{"key":"ref34","volume-title":"Opioid prescriptions decrease for 10th consecutive year","year":"2021"},{"key":"ref35","year":"2022"},{"key":"ref36","volume-title":"Opioid abuse in the U.S. and HHS actions to address opioid-drug related overdoses and deaths","year":"2015"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jama.2021.13300","article-title":"The helping to end addiction long-term (HEAL) initiative of the National Institutes of Health","volume":"326","author":"Baker","year":"2021","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s11606-020-06258-3","article-title":"Opioid prescribing and opioid risk mitigation strategies in the veterans health administration","volume":"35","author":"Sandbrink","year":"2020","journal-title":"J Gen Intern Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"836908","DOI":"10.3389\/fpsyt.2022.836908","article-title":"Medical cannabis and past-year cannabis use disorder among adult recreational users in the United States: results from a nationally representative sample","volume":"13","author":"Rubin-Kahana","year":"2022","journal-title":"Front Psychol"},{"key":"ref40","volume-title":"Marijuana and hallucinogen use among young adults reached all time-high in 2021","year":"2022"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1377\/hpb20210701.500845","article-title":"Cannabis legalization in the US: population health impacts","volume":"10","author":"Haffajee","year":"2021","journal-title":"Health Affairs Health Policy Brief"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/jamainternmed.2018.0266","article-title":"Association between US state medical cannabis laws and opioid prescribing in the Medicare part D population","volume":"178","author":"Bradford","year":"2018","journal-title":"JAMA Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.drugalcdep.2017.01.006","article-title":"Medical marijuana policies and hospitalizations related to marijuana and opioid pain reliever","volume":"173","author":"Shi","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1177\/0269881120914211","article-title":"Evaluating the co-use of opioids and cannabis for pain among current users using hypothetical purchase tasks","volume":"34","author":"Bergeria","year":"2020","journal-title":"J Psychopharmacol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jpain.2016.03.002","article-title":"Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain","volume":"17","author":"Boehnke","year":"2016","journal-title":"J Pain"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e0187795","DOI":"10.1371\/journal.pone.0187795","article-title":"Associations between medical cannabis and prescription opioid use in chronic pain patients: a preliminary cohort study","volume":"12","author":"Vigil","year":"2017","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/dar.12323","article-title":"Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: the impact of contextual factors","volume":"35","author":"Lucas","year":"2016","journal-title":"Drug Alcohol Rev"},{"key":"ref48","year":"2019"},{"key":"ref49","year":""},{"key":"ref50","year":""},{"key":"ref51","year":""},{"key":"ref52","doi-asserted-by":"publisher","first-page":"108334","DOI":"10.1016\/j.addbeh.2025.108334","article-title":"Rates and correlates of simultaneous use and mixing of alcohol, tobacco, and cannabis among adults who currently use alcohol and tobacco","volume":"167","author":"Kong","year":"2025","journal-title":"Addict Behav"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/acer.12698","article-title":"Simultaneous vs. concurrent use of alcohol and cannabis in the National Alcohol Survey","volume":"39","author":"Subbaraman","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s40429-023-00513-3","article-title":"Sex and gender differences in simultaneous alcohol and cannabis use: a narrative review","volume":"10","author":"Tomko","year":"2023","journal-title":"Curr Addict Rep"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"e12855","DOI":"10.1111\/jrh.12855","article-title":"Health care access barriers among metropolitan and nonmetropolitan populations of eight geographically diverse states, 2018","volume":"41","author":"Zahnd","year":"2025","journal-title":"J Rural Health"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"107699","DOI":"10.1016\/j.drugalcdep.2019.107699","article-title":"Changes in urban and rural cigarette smoking and cannabis use from 2007 to 2017 in adults in the United States","volume":"205","author":"Coughlin","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.2105\/AJPH.2013.301709","article-title":"Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States","volume":"104","author":"Keyes","year":"2014","journal-title":"Am J Public Health"},{"key":"ref58","first-page":"309","article-title":"Differences in prevalence of prescription opiate misuse among rural and urban probationers. Am J drug alcohol abuse","author":"Havens","year":"2007"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2147\/JMDH.S104807","article-title":"Information bias in health research: definition, pitfalls, and adjustment methods","volume":"9","author":"Althubaiti","year":"2016","journal-title":"J Multidiscip Healthc"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1623420\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:21:47Z","timestamp":1765210907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1623420\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":59,"alternative-id":["10.3389\/fpubh.2025.1623420"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1623420","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"article-number":"1623420"}}